1. Home
  2. PMCB vs POLA Comparison

PMCB vs POLA Comparison

Compare PMCB & POLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PharmaCyte  Biotech Inc.

PMCB

PharmaCyte Biotech Inc.

HOLD

Current Price

$0.49

Market Cap

6.3M

Sector

Health Care

ML Signal

HOLD

Logo Polar Power Inc.

POLA

Polar Power Inc.

HOLD

Current Price

$1.38

Market Cap

6.0M

Sector

Miscellaneous

ML Signal

HOLD

Company Overview

Basic Information
Metric
PMCB
POLA
Founded
1996
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Industrial Machinery/Components
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
6.3M
6.0M
IPO Year
2001
2016

Fundamental Metrics

Financial Performance
Metric
PMCB
POLA
Price
$0.49
$1.38
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
84.1K
135.0K
Earning Date
03-17-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$24,801,141.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3.14
52 Week Low
$0.47
$1.31
52 Week High
$1.51
$5.70

Technical Indicators

Market Signals
Indicator
PMCB
POLA
Relative Strength Index (RSI) 31.46 36.67
Support Level N/A $1.36
Resistance Level $0.57 $1.93
Average True Range (ATR) 0.03 0.09
MACD -0.00 -0.02
Stochastic Oscillator 20.99 12.77

Price Performance

Historical Comparison
PMCB
POLA

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a biotechnology company focused on developing cellular therapies for cancer based on its proprietary cellulose-based live cell encapsulation technology, Cell-in-a-Box. The technology is intended to be used as a platform for therapies for several types of cancer, including locally advanced, inoperable pancreatic cancer (LAPC). The current generation of the Company's product candidate is CypCaps. The Company is preparing to commercialize cellular therapies for cancer and advance clinical research and development, including a clinical trial in LAPC using encapsulated live cells. Its candidate therapy involves encapsulating genetically engineered human cells that convert an inactive chemotherapy drug into its active, cancer-killing form.

About POLA Polar Power Inc.

Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, backup DC generators, hybrid power systems, Li-Ion battery systems, Marine DC generators, and others. The company's geographical presence is in the United States, Canada, Australia and South Pacific Islands, Other Asia Pacific, Europe and Middle East, United Kingdom, and South Africa.

Share on Social Networks: